VET Stock Analysis: Vermilion Energy | NYSE
Oil & Gas E&P | NYSE, USA | Market Cap: 1.945m USD | 12M Return: 74.4% | CA9237251058 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 16.1M
Qual. Beats: 0
Rev. Trend: -78.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Vermilion Energy Inc. (NYSE: VET) is a Canada-based international oil and gas producer engaged in the acquisition, exploration, development, and optimization of hydrocarbon-producing properties. The company operates a geographically diversified portfolio spanning North America, Europe, and Australia, with core assets located in Western Canada (West Pembina region of Alberta), France (Aquitaine and Paris Basin), the Netherlands, Germany, Ireland, Croatia, Slovakia, Hungary, and Australia. Headquartered in Calgary and founded in 1994, Vermilion has been publicly traded since its 2010 IPO.
The company operates within the Oil & Gas Exploration & Production (E&P) subsector of the energy industry. A distinguishing feature of Vermilions business model is its emphasis on acquiring and optimizing already-producing assets rather than relying solely on greenfield exploration, which generally provides more predictable cash flow and lower development risk. Its international footprint across multiple jurisdictions also exposes the company to a mix of regulatory regimes, fiscal terms, and commodity-market dynamics uncommon among North American-focused peers.
- European natural gas prices drive Netherlands and Germany margins
- Windfall profit taxes threaten French and EU upstream economics
- West Pembina oil production anchors dividend and capital return program
| Net Income: -446.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.03 > 1.0 |
| NWC/Revenue: -0.03% < 20% (prev 27.35%; Δ -27.38% < -1%) |
| CFO/TA 0.17 > 3% & CFO 921.5m > Net Income -446.4m |
| Net Debt (1.32b) to EBITDA (305.7m): 4.32 < 3 |
| Current Ratio: 1.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (155.9m) vs 12m ago 0.10% < -2% |
| Gross Margin: 30.48% > 18% (prev 55.83%; Δ -25.35% > 0.5%) |
| Asset Turnover: 30.49% > 50% (prev 30.97%; Δ -0.48% > 0%) |
| Interest Coverage Ratio: -4.21 > 6 (EBIT TTM -484.4m / Interest Expense TTM 114.9m) |
| A: -0.00 (Total Current Assets 572.3m - Total Current Liabilities 572.8m) / Total Assets 5.49b |
| B: -0.37 (Retained Earnings -2.03b / Total Assets 5.49b) |
| C: -0.08 (EBIT TTM -484.4m / Avg Total Assets 6.10b) |
| D: 0.65 (Book Value of Equity 2.16b / Total Liabilities 3.33b) |
| Altman-Z'' = -1.06 = CCC |
| DSRI: 1.09 (Receivables 291.7m/299.6m, Revenue 1.86b/2.08b) |
| GMI: 1.83 (GM 55.83% / 30.48%) |
| AQI: 2.54 (AQ_t 0.07 / AQ_t-1 0.03) |
| SGI: 0.90 (Revenue 1.86b / 2.08b) |
| TATA: -0.25 (NI -446.4m - CFO 921.5m) / TA 5.49b) |
| Beneish M = -1.39 (Cap -4..+1) = D |
As of August 24, 2026, the stock is trading at USD 12.73 with a total of 853,388 shares traded. Over the past week, the price has changed by +12.26%, over one month by +13.26%, over three months by +8.46% and over the past year by +74.38%.
Current recommended Stop Loss: 12.10 (which is 4.9% or 1.4 ATR below the current price).
Vermilion Energy has received a consensus analysts rating of 3.80. Therefore, it is recommended to hold VET.
- StrongBuy: 3
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 27.2 | 113.8% |
Market Cap CAD = 2.68b (1.95b USD * 1.3784 USD.CAD)
P/E Forward = 35.8423
P/S = 1.0568
P/B = 1.2426
P/EG = 3.58
Revenue TTM = 1.86b CAD
EBIT TTM = -484.4m CAD
EBITDA TTM = 305.7m CAD
Long Term Debt = 1.31b CAD (from longTermDebt, last quarter)
Short Term Debt = 9.20m CAD (from shortTermDebt, last fiscal year)
Debt = 1.40b CAD (from shortLongTermDebtTotal, last quarter) + Leases 46.8m
Net Debt = 1.32b CAD (calculated: Debt 1.40b - CCE 81.8m)
Enterprise Value = 4.00b CAD (2.68b + Debt 1.40b - CCE 81.8m)
Interest Coverage Ratio = -4.21 (Ebit TTM -484.4m / Interest Expense TTM 114.9m)
EV/FCF = 11.87x (Enterprise Value 4.00b / FCF TTM 337.2m)
FCF Yield = 8.43% (FCF TTM 337.2m / Enterprise Value 4.00b)
FCF Margin = 18.13% (FCF TTM 337.2m / Revenue TTM 1.86b)
Net Margin = -24.00% (Net Income TTM -446.4m / Revenue TTM 1.86b)
Gross Margin = 30.48% ((Revenue TTM 1.86b - Cost of Revenue TTM 1.29b) / Revenue TTM)
Gross Margin QoQ = 31.84% (prev 25.43%)
Tobins Q-Ratio = 0.73 (Enterprise Value 4.00b / Total Assets 5.49b)
Interest Expense / Debt = 8.20% (Interest Expense 114.9m / Debt 1.40b)
Taxrate = 36.69% (78.0m / 212.7m)
NOPAT = -306.7m (EBIT -484.4m * (1 - 36.69%)) [loss with tax shield]
Current Ratio = 1.00 (Total Current Assets 572.3m / Total Current Liabilities 572.8m)
Debt / Equity = 0.65 (Debt 1.40b / totalStockholderEquity, last quarter 2.16b)
Debt / EBITDA = 4.32 (Net Debt 1.32b / EBITDA 305.7m)
Debt / FCF = 3.92 (Net Debt 1.32b / FCF TTM 337.2m)
Total Stockholder Equity = 2.29b (last 4 quarters mean from totalStockholderEquity)
RoA = -7.32% (Net Income -446.4m / Total Assets 5.49b)
RoE = -19.53% (Net Income TTM -446.4m / Total Stockholder Equity 2.29b)
RoCE = -13.48% (EBIT -484.4m / Capital Employed (Equity 2.29b + L.T.Debt 1.31b))
RoIC = -6.33% (negative operating profit) (NOPAT -306.7m / Invested Capital 4.85b)
WACC = 6.46% (E(2.68b)/V(4.08b) * Re(7.13%) + D(1.40b)/V(4.08b) * Rd(8.20%) * (1-Tc(0.37)))
Discount Rate = 7.13% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -88.43 | Cagr: -2.12%
[DCF] Terminal Value 77.97% ; FCFF base≈259.0m ; Y1≈296.9m ; Y5≈436.9m
[DCF] Fair Price = 34.38 (EV 6.57b - Net Debt 1.32b = Equity 5.25b / Shares 152.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.56 | # QB: 0
Revenue Correlation: -77.96 | Revenue CAGR: -4.39% | SUE: 0.18 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.07 | Chg30d=-22.22% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=0.49 | Chg30d=+19.51% | Revisions=+25% | GrowthEPS=+120.7% | GrowthRev=+5.2%
EPS next Year (2027-12-31): EPS=1.08 | Chg30d=+20.00% | Revisions=+25% | GrowthEPS=+120.4% | GrowthRev=+4.9%